Updated information for BSI clients on Periodic Safety Update Reports (PSURs) Industry Newsletters Regulatory Affairs NewsletterIndustry Newsletters Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter Archive

Updated information for BSI clients on Periodic Safety Update Reports (PSURs)

Following legislation amendments (EU)2023/607, (EU)2024/1860 and new PMS regulations applicable in Great Britain, BSI is providing updated information on PSUR. Topics covered in this communication: BSI PSUR evaluation process and PSUR submission timelines Combined reviews of PSUR under EU regulations and UK MDR PMS requirements for Great Britain PSURs for legacy devices placed on the market under the Directives PSUR…
Ben Kemp
October 31, 2025
Nexperia Semiconductor Supply Exposure — feedback for DHSC Membership NewsMembership News ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

Nexperia Semiconductor Supply Exposure — feedback for DHSC

DHSC have highlighted an emerging risk to the UK medical technology supply chain following recent developments involving Nexperia, a major global supplier of legacy semiconductors. The Dutch government’s recent intervention and the subsequent Chinese export ban on Nexperia products have disrupted a significant portion of the company’s supply chain, with potential implications for the availability of critical chips used in…
Ben Kemp
October 28, 2025
NICE recruiting HealthTech professional committee members Membership NewsMembership News Archive

NICE recruiting HealthTech professional committee members

NICE have a number of roles available across their three HealthTech Committees: Diagnostics advisory committee Medical technologies advisory committee Interventional procedures advisory committee Applicants may be appointed to any of the three committees, unless otherwise indicated during the interview process. They are particularly interested in candidates with experience in the following areas: NHS manager/NHS finance manager (multiple roles) Nurse or…
Ben Kemp
October 28, 2025
AI Growth Lab: Call for Evidence ConsultationsConsultations ArchiveMembership NewsMembership News ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

AI Growth Lab: Call for Evidence

The MHRA are seeking evidence on a pioneering cross-economy sandbox, that would oversee the deployment of AI-enabled products and services that current regulation hinders. The Lab would deliver more dynamic UK regulation. Regulatory decisions on novel technologies can often take years, but we know that regulatory sandboxes can accelerate time to market by 40%. The AI Growth Lab would support…
Ben Kemp
October 28, 2025
Infectious Diseases and Near Patient Working Party Agendas – 6th November Infectious Diseases Working PartyInfectious Diseases Working Party ArchiveMembership NewsMembership News ArchiveNear Patient Testing Working PartyNear Patient Testing Working Party Archive

Infectious Diseases and Near Patient Working Party Agendas – 6th November

The Infectious Diseases and Near Patient Working Parties are taking place back-to-back on Thursday 6th November. The Infectious Diseases Working Party agenda can be found here. Highlights include presentations on: Advancing the 100 Days Mission for Diagnostics: 2025 Global Gap Assessment Tuberculosis at home and away: diagnostic progress, pitfalls and prospects Update from the Fleming Initiative Register here. The Near…
Ben Kemp
October 28, 2025
First meeting of National Commission into the Regulation of AI in Healthcare Membership NewsMembership News Archive

First meeting of National Commission into the Regulation of AI in Healthcare

Last week, the MHRA convened the National Commission into the Regulation of AI in Healthcare for the first time. The Commission brings together global AI leaders, clinicians, regulators, and patient advocates to advise on future-ready frameworks for regulation of AI in health. BIVDA is a member of the Technology Working Group as part of the commission, represented by our Head…
Ben Kemp
October 28, 2025